Work

Preclinical Studies of the IAP Antagonist Debio 1143 in Combination with Cytarabine or Doxorubicin in a Mouse Model of AML

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.5296.5296

Authors: Ambrose Campbell, Ezhilarasi Chendamarai, Matthew Holt, Julie Prior, Linda Eissenberg, Michael P. Rettig, Gregoire Vuagniaux, Claudio Zanna, John F. DiPersio

Institutions: Saint Louis University, Washington University in St. Louis, Debiopharm (Switzerland)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2566579189

FWCI:

Cites:

Cited by:

Related to: 10